Search Results 851-860 of 18399 for Lactation
Pregnant or lactating women. 5. Have participated in any other investigational drug trial within 30 days of dosing or 5 half-lives (whichever is longer) in ...
Subject is lactating or breastfeeding. 16. Patient has a past medical history of or ongoing clinically relevant interstitial lung disease, drug-induced ...
Body mass index of 18-35 kg/m²; Female subjects must have negative urine pregnancy tests and must not be lactating prior to receiving study medication and ...
Pregnant or lactating women. 6. Participants will be ineligible if, in the opinion of the Investigator, they are unlikely to comply with the trial protocol ...
Women who are pregnant or lactating. Women of child-bearing potential (WOCBP) and fertile men with a WOCBP partner, not using adequate birth control ...
* Pregnant or lactating women * Known history of hepatitis B, hepatitis C requiring antiviral treatment * Human immunodeficiency virus (HIV)-infected ...
Women who are already pregnant or lactating. Known intolerance or hypersensitivity to MMB or DAN, their metabolites, or formulation excipients. Patients ...
* Lactating females are not eligible unless they have agreed not to breastfeed their infants starting with the first dose of study therapy through 5 months ...
Participation eligibility · Pregnancy: Women who are pregnant or lactating or are planning on becoming pregnant during the study · Asthma: Subjects with a current ...
- Females who are pregnant or lactating. The participant has previously received treatment with any CDK4 and CDK6 inhibitor. The participant is receiving ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.